Shadow of a Stout

The Success of Oncortaget Journal

Sep
26

Oncotarget is a peer-reviewed and open access medical journal based in the United States. The term Oncotarget includes all cellular functions, molecules, and pathways common in cancer and aging, lymphocytes and neurons, atherosclerosis and neurodegeneration, cancer cells, and microbes. It publishes papers online on a weekly basis. Besides, each issue can be printed on demand. It covers research based on all aspects of oncology. It was established in 2010 and is usually published by Impact Journals.

The journal is indexed and abstracted in Index Medicus, BIOSIS Previews, Science Citation Index Expanded, and Scopus. Oncotarget has a mission of ensuring that scientific results are widely and rapidly available, eliminating the border between specialties. It also focuses on maximizing the impact of research through insightful review, linking different fields of biomedical science to foster the application of clinical and basic science to avoid diseases. The journal has also enhanced exceptional discoveries are shared them widely and what Oncotarget knows.

With a leadership of the most prominent scientist, Oncortaget helps researchers contribute to the progress of science. The success of Oncotarget has prompted the launch of other sections beyond oncology such as Neuroscience, Cell biology, pharmacology, metabolism, Cardiology, Endocrinology among others. Its impact factor is at 5.168, with the ResearchGate data. It is based on the average citation counts from work published in the journal. It has enabled people whose journals are mistakenly rejected by leading journals to submit their papers to them with peer reviews sourced from the other journal and a rebuttal letter and more information click here.

Oncortarget will start publishing two issues per week instead of the one issue they were previously published due to increased demand. Oncotarget is giving alt-metric article reports free. They are doing that to provide a real-time tracking of articles in digital and traditional media channels on Facebook before accruing of traditional citations and Oncotarget lacrosse camp.

Oncotarget editors evaluate the manuscripts based on scientific novelty, merit, presentation and quality of data regardless of the authors’ sexual orientation, race, citizenship, and religious beliefs. Information in the manuscript is only disclosed to the authors, reviewers, and members of the editorial board. Therefore, the information is treated with confidentiality. Peer review is usually obligatory and essential as it helps editors make the right decisions, and they comment to the authors so that they improve on their manuscripts and what Oncotarget knows.

More Visit: www.scijournal.org/impact-factor-of-ONCOTARGET.shtml

Health and Heart, Health News Comments Off on The Success of Oncortaget Journal

Mikhail Blagosklonny Tenure at Oncotarget

Aug
25

It’s an international, weekly peer-reviewed open medical journal covering research on all aspects of oncology. It is a traditional multidisciplinary journal which is accessed freely. The journal was co-founded in 2010. Impact Journal, a renowned publisher recently published the oncotarget. Mikhail Blagosklonny and Andrei V. Gudkov are the editors- in- chief. Its goal is to make scientific results quickly and extensively available and to increase the effect of research through insightful review. It also gives room for exceptional findings to be shared quickly and connect different areas of biomedical science. Additionally, it has a mission of advancing applications of basic and clinical science to fight infection. The journal helps all researchers to contribute toward the advancement of science under the tenure of the most famous scientists. Oncotarget is a member and subscriber of the standards of the Committee on Publication Ethics. Its target is to employ treatment amenities to improve the management of cancer patients.

About Mikhail Blagoskylonny

Mikhail Blagosklonny is a scientist who specializes in cancer and aging-related issue. On April 15, 2009, he was made a professor of oncology at Roswell Park Cancer Institute in New York. He attended the First Pavlov State Medical University of St. Petersburg where he earned his M.D in Internal Medicine and Ph.D. in Experimental Medicine and Cardiology. Mikhail Blagosklonny served as senior scientist at Ordway Research Institute, New York. Before that, he served as an associate professor of medicine at New York Medical College, Valhalla.

Dr. Blagosklonny is an author of over 170 research articles, book chapters, and reviews. He is the Founding Editor and Editor-in-chief of Cell Cycle. He is also an Associate Editor of Cancer Biology and Therapy, Cancer Research, Cell Death and Differentiation, Autophagy, American Journal of Pathology, International Journal of Cancer, and PLOS ONE. He revealed potential targets for slowing down aging and diseases associated with age.Misha is an accomplished researcher with unique approaches in cancer biology and therapy. His presence will accelerate the development of new anti-cancer tactics and methods of cancer treatment and prevention. The Roswell fraternity was very anxious about his recruitment.

 

Cancer Studies, Health News Comments Off on Mikhail Blagosklonny Tenure at Oncotarget

InnovaCare Health’s Commitment to their Patients

Aug
10

It’s always good when a company’s committed to their customers. There’s a noticeable difference in customer service and the quality of their services. When it comes to healthcare management companies, patient-commitment is the most important thing. In some cases, it could be life or death.That’s why it’s so sad that some of those companies care more about their profit margins. Even worse, the current healthcare environment is a complicated place. The healthcare system is too complex for the average person to navigate through all the policies and get the medical care they, or a loved one, deserve.Fortunately, InnovaCare Health is a company wanting to change the business. In their opinion, it’s not the patients or even the companies that necessarily need to change. It’s more about redefining healthcare management and making things easier for everyone. If the current system focuses more on patients, than everyone wins.

No one understands that better than Penelope Kokkinides. As of 2015, Penelope Kokkinides is the Chief Administrative Officer of InnovaCare, Inc. Unlike her co-workers, she’s worked for InnovaCare once before. Prior to leaving the first time, she served as COO. She decided to leave to pursue other opportunities.Upon her return, she immediately began applying her expertise to the InnovaCare mission. With over 20 years’ experience in the managed care industry, working with government programs, she’s best suited for creating new health models for the company. She does have extensive knowledge of clinical programs and health care processes.While working for other companies, she learned new sets of skills.

She also served in higher-ranking roles at those companies. While serving as Executive VP and Chief Operating Officer at another company, she oversaw strategic direction for their managed care division. At another, she played a significant role in developing and implementing several managed care models.In addition to Kokkinides, InnovaCare also has Richard Shinto serving as the company’s leader. Dr. Shinto has also worked over 20 years in the managed care industry, but his focus was more on the best clinical healthcare. Unlike Kokkinides, Dr. Shinto’s an actual physician.Dr. Shinto is a practicing internist and pulmonologist. He’s also an author of several published articles featuring subjects such as healthcare and clinical medicines. His greatest accomplishment was making InnovaCare the top managed care company in Puerto Rico.

Health Insurance, Health News Comments Off on InnovaCare Health’s Commitment to their Patients

Make A Delicious Watermelon Smoothie With Markus Rothkranz

Nov
27

One of the best ways to beat the heat and stay healthy is with a nice refreshing watermelon smoothie. Markus Rothkranz is going to show us his favorite way to make the smoothie and other ways to use it, besides drinking it.

Many people wonder what type of watermelon they should even get. Should you get a regular seeded watermelon or a seedless organic watermelon? The truth of the matter is that you should always opt for fruits with their seeds, as they are much healthier for you. Seedless fruits will diminish your body’s natural reproductive health. However, the seedless organic melons don’t have pesticides or herbicides.

So if you’re going to just eat the watermelon straight, choose the seeded version. The seeds give you more vitality and power. For our smoothie however, we are going to use a whole organic seedless melon.

After you have picked out your watermelon, cut it into pieces small enough to fit into your blender. Make sure to include the rind because of its healthful properties and high level of bioflavonoids. Most people are initially afraid this will affect the way it tastes, but you’d actually be surprised. It actually tastes like watermelon!

Now blend it all together for ten to fifteen seconds or until it is all blended equally and pour yourself a big glass. Isn’t it amazing how simple it is to be healthy?

Another wonderful use for watermelons will probably surprise you. Scientists have discovered that putting the ground up watermelon on your face actually promotes younger looking skin. The lycopene feeds your skin, plumps it up, and helps revitalize your pores. You’ll be able to see a difference in just a few days of consistent use. Most people wonder how Markus looks so young at age 50. It’s probably because he actually lives healthy!

Health News Comments Off on Make A Delicious Watermelon Smoothie With Markus Rothkranz

Can You Afford Ill Health?

Feb
11

 

Do you feel as if you have been violated whenever you go to the pharmacy to obtain medication that you need, but cannot pay for? You are not alone in the world with this attitude. How can you not have a negative mood when you cannot afford the cost to get help your health issues? Where is an elderly or disabled person to turn for assistance?

What is more, baby boomers are about the age of 70 now, so the new drugs are getting pushed for speedier, longer, less painful recovery or some other new, successful technology. According to Dr. Sergio Cortes, people are living longer and healthier. Help is out there. Research the net and you will find help. Ask manufacturers for free help via applications.

Whenever one needs medication, he expects it to be readily available, and it if is not, a real cause for concern arises, possibly even panic if the health issue is one that cannot be treated with anything else but the particular drug in question. A limited income and the high cost of medications leave millions of people with serious illness or disability.

Drug Prices, Health News, US Comments Off on Can You Afford Ill Health?